Dr YHA Abdel-WahabSenior Lecturer in Biomedical SciencesContact details:+44 (0)28 70324354y.abdel-wahab@ulster.ac.ukBrief pr<strong>of</strong>ile:MB. BCh. (1985), Faculty <strong>of</strong> Medicine, Cairo <strong>University</strong>, Egypt and PhD (1993) from <strong>University</strong> <strong>of</strong> <strong>Ulster</strong>,Coleraine. Postdoctoral <strong>Research</strong> Fellow at Creighton <strong>University</strong>, School <strong>of</strong> Medicine, USA (1994-95),Postdoctoral <strong>Research</strong>er at the <strong>University</strong> <strong>of</strong> <strong>Ulster</strong> at Coleraine (1995-2007) before taking up current appointmentas Senior Lecturer in Biomedical Sciences at the <strong>University</strong> <strong>of</strong> <strong>Ulster</strong> in 2007. Dr Abdel-Wahabhas over 60 peer-reviewed publications, invited speaker at many national and international conferences andis a Patent holder.Main <strong>research</strong> interests:Discovery, targets and action <strong>of</strong> antidiabetic drugs from natural resourcesAntidiabetic actions <strong>of</strong> structurally modified peptidesGlycation <strong>of</strong> pancreatic islet peptides and proteinsStem cell and gene therapy in diabetes.Publications:Abdel-Wahab YHA, Maranah L, Flatt PR, Conlon JM; Insulin releasing properties <strong>of</strong> the temporin family <strong>of</strong> antimicrobialpeptides; Europe Protein & Peptide Letters, 14: 702-707, 2007Hannan JMA, Marenah L, Ali L, Rokeya B, Flatt PR and Abdel-Wahab YHA; Insulin secretory actions <strong>of</strong> extracts <strong>of</strong>Asparagus racemosus root in perfused pancreas, isolated islets and clonal pancreatic B-cells; Journal <strong>of</strong> Endocrinology,192: 159-168, 2007Hannan JMA, Ali L, Rokeya B, Khaleque J, Akhter M, Flatt PR and Abdel-Wahab YHA; Soluble dietary fibre fraction <strong>of</strong>Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in type 1 and type 2 diabetes by delayingcarbohydrate digestion, absorption and enhancing insulin action; British Journal <strong>of</strong> Nutrition, 97: 514-521, 2007Abdel-Wahab YHA, Power GJ, Ng MT, Flatt PR, Conlon JM; Insulin-releasing properties <strong>of</strong> the frog skin peptidepseudin-2 and its [Lys 18 ] substituted analogue; Biological Chemistry, 389: 143-148, 2008Abdel-Wahab YHA, Power GJ, Flatt PR, Woodhams DC, Rollins-Smith LA, Conlon JM; A peptide <strong>of</strong> thephylloseptin family from the skin <strong>of</strong> the frog Hylomantis lemur (Phyllomedusinae) with potent in vitro and invivo insulin-releasing activity; Peptides, 29: 2136-2143, 2008Conlon JM, Power GJ, Abdel-Wahab YHA, Flatt PR, Jiansheng H, Coquet L, Leprince J, Jouenne T, Vaudry H; Apotent, non-toxic insulin-releasing peptide isolated from an extract <strong>of</strong> the skin <strong>of</strong> the Asian frog, Hylarana güntheri(Anura:Ranidae); Regulatory peptides, 151: 153-159, 2008Conlon JM, Abdel-Wahab YHA, Flatt PR, Leprince J; A glycine-leucine-rich peptide structurally related to the plasticinsfrom skin secretions <strong>of</strong> the frog Leptodactylus laticeps (Leptodactylidae); Peptides (in press)48
Dr AM McKillopSenior Lecturer in Clinical & Endocrine BiochemistryContact Details:T: +44 (0)28 70323066am.mckillop@ulster.ac.ukBrief pr<strong>of</strong>ile:BSc Hons and PhD from Queen’s <strong>University</strong>, Belfast and MSc from the <strong>University</strong> <strong>of</strong> <strong>Ulster</strong>. Postdoctoral<strong>Research</strong> Fellow at Queen’s <strong>University</strong>, Belfast (1996-98) and the <strong>University</strong> <strong>of</strong> <strong>Ulster</strong> at Coleraine (1998-02) before taking up current appointment as Lecturer in Clinical Biochemistry at the <strong>University</strong> <strong>of</strong> <strong>Ulster</strong> in2002. Patent holder and over 40 peer-reviewed publications and presentations at national and internationalconferences.Main <strong>research</strong> interests:• clinical biochemistry and diabetes proteomics• cellular glucose handling and metabolism• pancreatic beta-cell peptides and proteins• mechanisms <strong>of</strong> insulin resistance and diabetes pathogenesis• glycation <strong>of</strong> insulin and other key regulatory proteins• structural and functional characterization <strong>of</strong> novel biomolecules• insulin receptor dysfunction and novel treatments for diabetes.During the year under review, Dr McKillop obtained a pilot grant (£10,000) from the <strong>University</strong> “Pre-Pro<strong>of</strong> <strong>of</strong>Concept Scheme” to support a recently successful application to Invest Northern Ireland for a Pro<strong>of</strong> <strong>of</strong> Conceptgrant (£70,340) to investigate: “Intestinal Biomarkers for Diabetes”.Publications:Duffy N, Green BD, Irwin N, Gault VA, McKillop AM, O’Harte FPM, Flatt PR; Effects <strong>of</strong> antidiabetic drugs in dipeptidylpeptidase IV: Nateglinide is an inhibitor <strong>of</strong> DPPIV and augments antidiabetic activity <strong>of</strong> glucagon-like peptide-1;European Journal <strong>of</strong> Pharmacology, 568: 278-286, 2007McKillop AM, Duffy NA, Lindsay JR, O’Harte FPM, Bell PM, Flatt PR; Decreased dipeptidyl peptidase-IV activity andglucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects; Diabetes Res Clin Pract., 79: 79-85, 2008McKillop, AM., Flatt PR; Recent Developments in the Search for Biomarkers for the Diagnosis and Monitoring <strong>of</strong>Diabetes; Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, 2: 172-177, 2008Taylor A, Irwin N, McKillop AM, Flatt PR, Gault VA; Sub-chronic administration <strong>of</strong> 11beta-HSD1 inhibitor, carbenoxolone,improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity; Biological Chemistry, 389: 441-445,200849
- Page 1: BIOMEDICAL SCIENCESRESEARCH INSTITU
- Page 4 and 5: 1 Foreword by the Pro Vice-Chancell
- Page 6 and 7: 2 Foreword by the Research Institut
- Page 8 and 9: The BMSRI Research StructureThe BMS
- Page 10 and 11: BMSRI Core FacilitiesContact: Karen
- Page 12 and 13: of Metabolomics, pharmacy, nutritio
- Page 14 and 15: BMSRI Academic Heads new Regional N
- Page 16 and 17: 4. BIOMEDICAL GENOMICS RESEARCH GRO
- Page 18 and 19: Recent Funding Initiatives:C-TRIC:
- Page 20 and 21: Dr Mateus Webba da SilvaLecturer in
- Page 22 and 23: 5. BIOIMAGING RESEARCH GROUPResearc
- Page 24 and 25: developmental alterations that mani
- Page 26 and 27: Publications:Bigot S, Lucas L, Morr
- Page 28 and 29: Publications:Barnes CA, O’Hagan B
- Page 30 and 31: We also measure the genotoxic effec
- Page 32 and 33: 6. CANCER AND AGEING RESEARCH GROUP
- Page 34 and 35: Professor Anthony P McHaleProfessor
- Page 36 and 37: Professor Stephanie McKeownProfesso
- Page 38 and 39: an Alzheimer Research Trust collabo
- Page 40 and 41: JM, Waugh DJJ; Dexamethasone potent
- Page 42 and 43: have wider applications in vivo, in
- Page 44 and 45: Inter-relationships between diet an
- Page 46 and 47: Flatt PR; Effective surgical treatm
- Page 48 and 49: These areas are the subject of seve
- Page 52 and 53: Dr VA GaultLecturer in Molecular Bi
- Page 54 and 55: McClean PL, Irwin N, Hunter K, Gaul
- Page 56 and 57: Publications:Duffy NA, Green BD, Ir
- Page 58 and 59: 8. MICROBIOLOGY AND BIOTECHNOLOGYRE
- Page 60 and 61: Publications:Graham RJL, Graham C,
- Page 62 and 63: analyses. However there is still a
- Page 64 and 65: Plessas S, Bekatorou A, Koutinas AA
- Page 66 and 67: Biochemical studies/ viral evasion
- Page 68 and 69: Dr Stephen McCleanLecturer in Prote
- Page 70 and 71: environmental remediation and as ro
- Page 72 and 73: 9. NORTHERN IRELAND CENTRE FOR FOOD
- Page 74 and 75: 26-28 Sept 2007: International Seaf
- Page 76 and 77: Dr Barnes has developed expertise i
- Page 78 and 79: Dr Alison GallagherSenior Lecturer
- Page 80 and 81: In addition, results of a pilot stu
- Page 82 and 83: Dr Maeve KerrResearch AssociateCont
- Page 84 and 85: Memberships of External Committees/
- Page 86 and 87: Indicators of Esteem:Professor McNu
- Page 88 and 89: were examined. The intervention and
- Page 90 and 91: Within this work both short-term an
- Page 92 and 93: micronutrient supplementation at a
- Page 94 and 95: 10. STEM CELL & EPIGENETICS RESEARC
- Page 96 and 97: Publications:Lees-Murdock DJ, Lau H
- Page 98 and 99: Publications:Lees-Murdock DJ, Lau H
- Page 100 and 101:
11. SYSTEMS BIOLOGY RESEARCH GROUPT
- Page 102 and 103:
Kravtsov V, Swain M, Schuster A, Du
- Page 104 and 105:
Dr Daniel BerrarLecturer in Biomedi
- Page 106 and 107:
Zhang et al; Incorporating Feature
- Page 108 and 109:
Bala P, Baldridge K, Benfenati E, C
- Page 110 and 111:
In addition there is a growing them
- Page 112 and 113:
Clinical work involves development
- Page 114 and 115:
In 2009 he was appointed Chairman o
- Page 116 and 117:
Stevenson TR, Goodall EA and Moore
- Page 118 and 119:
Dr Raymond BeirneLecturer in Optome
- Page 120 and 121:
Dr Julie McClellandLecturer in Opto
- Page 122 and 123:
Graham JE, Moore JE, Moore JE, McCl
- Page 124 and 125:
Research Staff:Dr David OrrSenior R
- Page 126 and 127:
Dr Victoria McGilliganResearch Asso
- Page 128 and 129:
13. Externally Funded Projects duri
- Page 130 and 131:
Grant Holder Anderson, Prof RSFundi
- Page 132 and 133:
Funding Body Royal Irish AcademyAmo
- Page 134 and 135:
14. BIOMEDICAL SCIENCES RESEARCH IN
- Page 136 and 137:
Student: Simon GenglerTitle: Effect
- Page 138 and 139:
Student: Anisha MazumdarTitle: Anal
- Page 140 and 141:
Student: Clare RyanTitle: How does
- Page 142 and 143:
CONGRATULATIONS TO THE FOLLOWING PO